Literature DB >> 35094380

Molecular evidence for selinexor as a treatment for Merkel cell polyomavirus (MCPyV)-positive Merkel cell carcinoma.

Brooke R Bartley1, Rebecca A Simonette1, Peter L Rady1, Hung Q Doan2, Stephen K Tyring1.   

Abstract

Entities:  

Year:  2022        PMID： 35094380     DOI： 10.1111/ijd.16057

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  1 in total

Review 1.  The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review.

Authors:  Jennifer R Landes; Stephen A Moore; Brooke R Bartley; Hung Q Doan; Peter L Rady; Stephen K Tyring
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-08       Impact factor: 4.322
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.